Mutational Landscape of the Proglucagon-Derived Peptides

Mutational Landscape of the Proglucagon-Derived Peptides

Strong efforts have been placed on understanding the physiological roles and therapeutic potential of the proglucagon peptide hormones including glucagon, GLP-1 and GLP-2. However, little is known about the extent and magnitude of variability in the amino acid composition of the proglucagon precurso...

Full description

Bibliographic Details
Main Authors:	Peter Lindquist, Jakob S. Madsen, Hans Bräuner-Osborne, Mette M. Rosenkilde, Alexander S. Hauser
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Endocrinology
Subjects:	proglucagon pharmacogenomics GLP-1 GLP-2 glucagon GPCR
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.698511/full

Similar Items

Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals
by: David M. Irwin, et al.
Published: (2021-07-01)

Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
by: Jens Juul Holst
Published: (2022-08-01)

GLP-1 localisation and proglucagon gene expression in healthy and diabetic mouse ileum
by: Taşçı Serap Koral, et al.
Published: (2018-07-01)

Editorial: Proglucagon-Derived Peptides
by: Peter R. Flatt, et al.
Published: (2021-11-01)

Small intestine morphology and recovery after drug-induced colitis in proglucagon-derived peptides knockout mice
by: Masanobu Matsushita, et al.
Published: (2016-12-01)

Glucagon‐like peptide agonists: A prospective review
by: Zamara Mariam, et al.
Published: (2024-01-01)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
by: Jens Juul Holst
Published: (2019-04-01)

Glucagon Shows Higher Sensitivity than Insulin to Grapeseed Proanthocyanidin Extract (GSPE) Treatment in Cafeteria-Fed Rats
by: Carme Grau-Bové, et al.
Published: (2021-03-01)

Limited impact on glucose homeostasis of leptin receptor deletion from insulin- or proglucagon-expressing cells
by: Helen Soedling, et al.
Published: (2015-09-01)

Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system
by: Sarina Gadgaard, et al.
Published: (2023-04-01)

The effects of Fc fusion protein glucagon-like peptide-1 and glucagon dual receptor agonist with different receptor selectivity in vivo studies
by: Peng Jiang, et al.
Published: (2024-05-01)

Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent
by: Syed Faizan Mehdi, et al.
Published: (2023-05-01)

Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
by: A. Delgado, et al.
Published: (2021-04-01)

Multifaceted Roles of GLP-1 and Its Analogs: A Review on Molecular Mechanisms with a Cardiotherapeutic Perspective
by: Sudhir Pandey, et al.
Published: (2023-06-01)

Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review
by: Teshome G, et al.
Published: (2020-09-01)

Evolution of GCGR family ligand-receptor extensive cross-interaction systems suggests a therapeutic direction for hyperglycemia in mammals
by: Liu Jian, et al.
Published: (2023-11-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes
by: Xin Zhang, et al.
Published: (2021-07-01)

The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping Review
by: Khang Duy Ricky Le, et al.
Published: (2024-01-01)

G protein-coupled receptors and obesity
by: Alessandro Pocai
Published: (2023-12-01)

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
by: Patrick J. Knerr, et al.
Published: (2022-09-01)

Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism
by: Kyle D. Medak, et al.
Published: (2023-03-01)

Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon
by: Keizo Kanasaki, et al.
Published: (2019-05-01)

Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
by: Dorte B. Zilstorff, et al.
Published: (2024-03-01)

Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01)

Anatomical and Functional Characterization of Central Amygdala Glucagon-Like Peptide 1 Receptor Expressing Neurons
by: Ningxiang Zeng, et al.
Published: (2021-12-01)

Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes
by: Scott A. Campbell, et al.
Published: (2020-09-01)

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

Identification of key genes and pathways revealing the central regulatory mechanism of brain-derived glucagon-like peptide-1 on obesity using bioinformatics analysis
by: Yuwei Shao, et al.
Published: (2022-08-01)

Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
by: Alorfi NM, et al.
Published: (2022-08-01)

Glucose metabolism and incretins level in morbidly obese patients and in patients after biliopancreatic diversion performed for morbid obesity
Published: (2014-03-01)

The Levels of Ghrelin, Glucagon, Visfatin and Glp-1 Are Decreased in the Peritoneal Fluid of Women with Endometriosis along with the Increased Expression of the CD10 Protease by the Macrophages
by: Aleksey M. Krasnyi, et al.
Published: (2022-09-01)

Tirzepatide: A Systematic Update
by: Imma Forzano, et al.
Published: (2022-11-01)

Consequences on islet and incretin hormone responses to dinner by omission of lunch in healthy men
by: Ola Lindgren, et al.
Published: (2020-07-01)

Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
by: David C. D. Hope, et al.
Published: (2021-09-01)

Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity?
by: C. Meurot, et al.
Published: (2022-01-01)

Effects of Exercise Training and IL-6 Receptor Blockade on Gastric Emptying and GLP-1 Secretion in Obese Humans: Secondary Analyses From a Double Blind Randomized Clinical Trial
by: Louise Lang Lehrskov, et al.
Published: (2019-10-01)

GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
by: Nyan Abdalqadir, et al.
Published: (2022-10-01)

Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
by: Phil Pickford, et al.
Published: (2021-09-01)

Self-assembled GLP-1/glucagon peptide nanofibrils prolong inhibition of food intake
by: Myriam M. Ouberai, et al.
Published: (2023-07-01)